Developer docs
API playgroundTry for free, no card

Search company profiles

World Health Organization

Full company profile

uuid00000fn

Namestring
World Health Organization
Legal namestring
World Health Organization
Websiteurl
who.int
Company typeenum
Private
Founded yearint
1948
Short descriptiontext

The World Health Organization is a UN specialized agency that coordinates international public health for 194 member states through normative guidance, disease surveillance, emergency response, and capacity building across six regional and 150+ country offices.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
5,001–10,000
akta.pro rankint
HeadquartersGeneva, Switzerland
HQ citystring
Geneva
HQ countrystring
Switzerland
HQ regionstring
Europe
Markets served

Serves global market

Offices15 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
global public health, health policy guidance, disease surveillance systems, emergency health response, health system strengthening
Industry4 codes
1Multilateral Global Health Agencies (UN/IFIs)
CodeHLAJAKAAPrimaryYes
2United Nations System & Specialized Agencies
CodeBPADAAAAPrimaryNo
3Global Health & Population Intergovernmental Bodies
CodeBPADAAADPrimaryNo
4Public Health Governance, Interagency Coordination & Partnerships
CodeHLAJAMADPrimaryNo
NAICS code4 codes
  • International Affairs92812
  • International Affairs928120
  • Administration of Public Health Programs92312
  • Public Administration92
SIC code3 codes
  • International Affairs9721
  • Foreign Governments8888
  • Services-Membership Organizations8600
Product category
International Public Health
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Assessed Contributions from Member States
TypeSubscription Recurring
Description

WHO is primarily funded through mandatory contributions from its 194 member states, based on a scale of assessment. These assessed contributions form the core predictable financing for WHO's base programmes.

who.int
2Voluntary Contributions
TypeSubscription Recurring
Description

Member states and other partners provide voluntary contributions for specific health programmes and initiatives. These flexible funds support priority health areas identified by donors and WHO.

who.int
3WHO Foundation and Partnership Funding
TypeGrants Donations
Description

WHO works with the WHO Foundation and various partnerships to mobilize additional resources for global health initiatives, including the Pandemic Fund and other thematic funding mechanisms.

who.int
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 3 records shown
1WHO Academy
Description

A state-of-the-art learning institution providing new learning opportunities for WHO staff and public health professionals globally.

who.int
+2 more records
Core offering1 text field

WHO is the United Nations specialized agency for international public health, serving 194 member states through setting international health norms and standards, providing technical cooperation and capacity building to national health systems, coordinating international responses to health emergencies and disease outbreaks, and maintaining global disease surveillance and health data systems. It develops evidence-based guidelines, disseminates open-access research, runs the Emergency Use Listing procedure for diagnostics and vaccines during emergencies, and operates the WHO Academy for public health workforce learning.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • Global health emergencies responded to including Ebola, COVID-19, mpox, cholera, and other disease outbreaks
+2 more records
Product overview1 text field

WHO is an international health organization that operates primarily as a public health agency rather than a software product company. Its digital offerings include the main WHO website and TDR Gateway publishing platform for tropical disease research. Key initiatives include the Global Research Agenda on Knowledge Translation with 19 priority research areas, the NAVIS Andes virus research initiative across 21 countries, and the first open-access global STI prevalence database. WHO provides the HeRAMS system for monitoring health resources, operates the Health Inequality Monitoring Network across 24 institutions, and maintains the WHO Academy for professional development. The organization also publishes multiple open-access journals and manages the Emergency Use Listing procedure for diagnostics during health emergencies. All WHO publications are available through its Institutional Repository (IRIS) under open-access licenses.

Product and service15 records
1WHO Website and Digital Platforms
CategoryDigital health information platform
2TDR Gateway
CategoryResearch publishing platform
3Global STI Prevalence Database
CategoryGlobal health data and surveillance
4HeRAMS (Health Resources and Services Availability Monitoring System)
CategoryHealth information system
5Emergency Use Listing (EUL)
CategoryRegulatory and emergency assessment procedure
6Hinari Access to Research for Health Programme
CategoryResearch access programme
7WHO Academy
CategoryPublic health training and learning
8WHO Institutional Repository for Information Sharing (IRIS)
CategoryOpen-access publication repository
9Health Inequality Monitoring Network
CategoryGlobal health research network
10WHO Open Access Journals
CategoryOpen-access scientific journals
11NAVIS (Andes Virus Research Initiative)
CategoryOutbreak research initiative
12WHO Pandemic Agreement
CategoryInternational legal framework
13Assistive Technology Repair and Recycling Guidance
CategoryTechnical guidance and standards
14Global Research Agenda on Knowledge Translation
CategoryResearch agenda and policy framework
15R&D Blueprint
CategoryEpidemic preparedness research framework
Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership17 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-07-10
Description

WHO and FAO jointly inform the Codex Alimentarius Commission, which adopted new international guidelines on precautionary allergen labelling (PAL). Seven joint FAO/WHO expert consultations informed these guidelines, establishing a harmonized science- and risk-based approach for 'may contain' statements as a voluntary international benchmark.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-07-07
Description

WHO and IPU held their annual Global Parliamentary Forum during the 79th World Health Assembly, gathering parliamentarians to discuss implementing the WHO Pandemic Agreement and securing sustainable financing for healthcare systems.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-07-02
Description

WHO sponsors the PARTNERS clinical trial for Bundibugyo Ebola treatments, coordinated by INRB (DRC's National Institute for Biomedical Research), Oxford University, and the Institute of Tropical Medicine Antwerp.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-07-02
Description

University of Oxford serves as the coordinating office for the WHO-sponsored PARTNERS clinical trial testing MBP134 antibody and remdesivir against Bundibugyo Ebola. Oxford's Pandemic Sciences Institute leads trial operations.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-07-02
Description

WHO and Africa CDC launched a Joint Continental Incident Management Support Team in Kampala to coordinate Ebola outbreak response across DRC and Uganda. Africa CDC is seeking $26 million for therapeutic trials.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-07-02
Description

Gilead Sciences donated 2,000 vials of remdesivir for the WHO-sponsored PARTNERS clinical trial in DRC. Remdesivir is one of two treatments being evaluated against the Bundibugyo Ebola strain.

Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-07-02
Description

Mapp Biopharmaceutical's experimental MBP134 monoclonal antibody cocktail is being tested in the WHO-sponsored PARTNERS clinical trial for Bundibugyo Ebola treatment.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-07-02
Description

The Institute of Tropical Medicine in Belgium is a key scientific partner in the WHO-sponsored PARTNERS clinical trial for Bundibugyo Ebola treatments, collaborating with INRB and Oxford University.

Strategic tierCoreTypeImplementation/ SI/ Consulting PartnerAnnounced on2026-07-02
Description

ALIMA is providing clinical trial support and patient care in the Ebola response, with healthcare workers administering trials while treating patients in isolation wards.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-26
Description

WHO jointly implemented with UNICEF, UNFPA, and the Ishonch Fund a $43.5 million healthcare programme in Uzbekistan, modernizing 231 perinatal institutions and training over 80,000 healthcare workers.

Strategic tierCoreTypeImplementation/ SI/ Consulting PartnerAnnounced on2026-06-25
Description

MSF is providing frontline medical care in the Ebola outbreak response in DRC, operating treatment centers and supporting patient care in isolation wards.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-25
Description

WHO, PAHO, and the Ibero-American Road Safety Observatory held their first joint meeting in Madrid, bringing together road safety leaders from 22 Ibero-American and Caribbean countries.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-24
Description

UNICEF and Gavi have launched a global outreach programme inviting vaccine developers for the Bundibugyo Ebola strain. UNICEF procures and delivers vaccines during outbreaks.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-12
Description

UKHSA leads the Hantavirus Collaborative Open Research Consortium (CORC), mobilizing over 1,600 experts from 130+ countries to coordinate international research activities following the MV Hondius outbreak.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-12
Description

ANRS-MIE supports coordination of the NAVIS natural history study for Andes virus across 21 countries under BE READY, an EU-funded initiative for epidemic research preparedness.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-12
Description

ISARIC provides its adaptable research framework for the NAVIS study, enabling rapid, standardized data and sample collection during the Andes virus outbreak.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

WHO collaborates with UNDP through TDR and the Global Action Plan for Healthy Lives and Well-being for All, working with 12 partner organizations to achieve health-related Sustainable Development Goals.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeRegional player
Description

EU regional disease-prevention agency with comparable surveillance and normative functions for Europe; partners with WHO EURO but serves a distinct geography.

TypeDirect peer
Description

Direct UN system peer sharing the same multilateral intergovernmental model with universal membership, assessed contributions, and joint country-level delivery on health-adjacent mandates (immunization, nutrition, maternal/child health).

TypeDirect peer
Description

Closely comparable UN system sibling; jointly runs TDR with WHO and co-implements health-systems-strengthening programmes, sharing governance, funding, and country-delivery models.

TypeDirect peer
Description

Co-governor of TDR and major co-financier of health systems work; comparable in scale, sovereign governance, and global development mandate, frequently partnering on pandemic preparedness and country-level health investments.

TypeDirect peer
Description

UN specialized agency sharing WHO's headquarters city, governance structure, and joint programmes; they jointly run Codex Alimentarius, making FAO an immediate operational peer.

6U.S. Centers for Disease Control and Prevention (CDC)
TypeBroad incumbent
Description

National public-health agency with overlapping technical functions (surveillance, lab capacity, outbreak response, normative guidance) and significant funding footprint; operates nationally rather than multilaterally but is a frequent operational partner.

TypeEmerging player
Description

Continental public-health body increasingly coordinating African outbreak response (e.g., Bundibugyo Ebola) and seeking its own financing; partial overlap with WHO's regional delivery in Africa and a potential future alternative coordinator.

TypeEmerging player
Description

Public-private partnership that funds vaccine procurement and outbreak response (including committed Bundibugyo financing); partners closely with WHO but is a downstream funding mechanism rather than a normative body.

TypeEmerging player
Description

Epi preparedness financing and coordination body that co-funds vaccine R&D with WHO (e.g., Bundibugyo vaccine development), partially overlapping WHO's R&D Blueprint function.

TypeOthers
Description

Operational NGO partner providing frontline medical care (e.g., Bundibugyo Ebola response); adjacent enabler/implementer rather than a normative peer, but routinely collaborates with WHO on emergencies.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration5 records

Each record includes

Title, Type, Description, Source

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles18 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries14 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment2 records

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

World Health Organization

International Public Healthwho.int

The World Health Organization is a UN specialized agency that coordinates international public health for 194 member states through normative guidance, disease surveillance, emergency response, and capacity building across six regional and 150+ country offices.

World Health Organization firmographics

Firmographics
Name
World Health Organization
Legal name
World Health Organization
Website
https://who.int
Company type
Private
Founded year
1948
Operating status
Operating
Headcount range
5,001–10,000 employees
Short description
The World Health Organization is a UN specialized agency that coordinates international public health for 194 member states through normative guidance, disease surveillance, emergency response, and capacity building across six regional and 150+ country offices.
Ownership category
akta.pro rank

World Health Organization industry classification

Industry
Product category
International Public Health
NAICS
International Affairs (92812), International Affairs (928120), Administration of Public Health Programs (92312), Public Administration (92)
SIC
International Affairs (9721), Foreign Governments (8888), Services-Membership Organizations (8600)
akta.pro primary industry
Multilateral Global Health Agencies (UN/IFIs) (HLAJAKAA)
akta.pro secondary industries
United Nations System & Specialized Agencies (BPADAAAA), Global Health & Population Intergovernmental Bodies (BPADAAAD), Public Health Governance, Interagency Coordination & Partnerships (HLAJAMAD)

Keywords

  • Global public health
  • Health policy guidance
  • Disease surveillance systems
  • Emergency health response
  • Health system strengthening

Where World Health Organization is headquartered

Location

Headquarters

HQ city
Geneva
HQ country
Switzerland
HQ region
Europe

Offices15 records

Markets served

World Health Organization business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales, Others

Revenue model

  1. Assessed Contributions from Member States: WHO is primarily funded through mandatory contributions from its 194 member states, based on a scale of assessment. These assessed contributions form the core predictable financing for WHO's base programmes.
  2. Voluntary Contributions: Member states and other partners provide voluntary contributions for specific health programmes and initiatives. These flexible funds support priority health areas identified by donors and WHO.
  3. WHO Foundation and Partnership Funding: WHO works with the WHO Foundation and various partnerships to mobilize additional resources for global health initiatives, including the Pandemic Fund and other thematic funding mechanisms.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

World Health Organization product offering

Product offering

Core offering

WHO is the United Nations specialized agency for international public health, serving 194 member states through setting international health norms and standards, providing technical cooperation and capacity building to national health systems, coordinating international responses to health emergencies and disease outbreaks, and maintaining global disease surveillance and health data systems. It develops evidence-based guidelines, disseminates open-access research, runs the Emergency Use Listing procedure for diagnostics and vaccines during emergencies, and operates the WHO Academy for public health workforce learning.

Product overview

WHO is an international health organization that operates primarily as a public health agency rather than a software product company. Its digital offerings include the main WHO website and TDR Gateway publishing platform for tropical disease research. Key initiatives include the Global Research Agenda on Knowledge Translation with 19 priority research areas, the NAVIS Andes virus research initiative across 21 countries, and the first open-access global STI prevalence database. WHO provides the HeRAMS system for monitoring health resources, operates the Health Inequality Monitoring Network across 24 institutions, and maintains the WHO Academy for professional development. The organization also publishes multiple open-access journals and manages the Emergency Use Listing procedure for diagnostics during health emergencies. All WHO publications are available through its Institutional Repository (IRIS) under open-access licenses.

Differentiator

Problem solved

Functional benefit

Brands

  • WHO Academy: A state-of-the-art learning institution providing new learning opportunities for WHO staff and public health professionals globally.
  • WHO Foundation
  • Hinari Access to Research for Health Programme

Products and services

  • WHO Website and Digital Platforms
  • TDR Gateway
  • Global STI Prevalence Database
  • HeRAMS (Health Resources and Services Availability Monitoring System)
  • Emergency Use Listing (EUL)
  • Hinari Access to Research for Health Programme
  • WHO Academy
  • WHO Institutional Repository for Information Sharing (IRIS)
  • Health Inequality Monitoring Network
  • WHO Open Access Journals
  • NAVIS (Andes Virus Research Initiative)
  • WHO Pandemic Agreement
  • Assistive Technology Repair and Recycling Guidance
  • Global Research Agenda on Knowledge Translation
  • R&D Blueprint

Quantifiable outcome

  • Global health emergencies responded to including Ebola, COVID-19, mpox, cholera, and other disease outbreaks
  • +2 more outcomes

Companies that use World Health Organization

Customer profile

Named customers4 records

Segments4 records

Ideal customer profiles3 records

World Health Organization technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability4 records

Feature4 records

World Health Organization partnerships and signals

Strategic signal

Partnerships

17 partnerships are on record, tiered core.

  • FAO - Food and Agriculture OrganizationcoreStrategic or Co-development Partner · 10 July 2026WHO and FAO jointly inform the Codex Alimentarius Commission, which adopted new international guidelines on precautionary allergen labelling (PAL). Seven joint FAO/WHO expert consultations informed these guidelines, establishing a harmonized science- and risk-based approach for 'may contain' statements as a voluntary international benchmark.
  • IPU - Inter-Parliamentary UnioncoreStrategic or Co-development Partner · 7 July 2026WHO and IPU held their annual Global Parliamentary Forum during the 79th World Health Assembly, gathering parliamentarians to discuss implementing the WHO Pandemic Agreement and securing sustainable financing for healthcare systems.
  • INRB - Institut National pour la Recherche Biomédicale (DRC)coreStrategic or Co-development Partner · 2 July 2026WHO sponsors the PARTNERS clinical trial for Bundibugyo Ebola treatments, coordinated by INRB (DRC's National Institute for Biomedical Research), Oxford University, and the Institute of Tropical Medicine Antwerp.
  • University of OxfordcoreStrategic or Co-development Partner · 2 July 2026University of Oxford serves as the coordinating office for the WHO-sponsored PARTNERS clinical trial testing MBP134 antibody and remdesivir against Bundibugyo Ebola. Oxford's Pandemic Sciences Institute leads trial operations.
  • Africa CDCcoreStrategic or Co-development Partner · 2 July 2026WHO and Africa CDC launched a Joint Continental Incident Management Support Team in Kampala to coordinate Ebola outbreak response across DRC and Uganda. Africa CDC is seeking $26 million for therapeutic trials.
  • Gilead SciencescoreTechnology or Integration · 2 July 2026Gilead Sciences donated 2,000 vials of remdesivir for the WHO-sponsored PARTNERS clinical trial in DRC. Remdesivir is one of two treatments being evaluated against the Bundibugyo Ebola strain.
  • Mapp Biopharmaceutical Inc.coreTechnology or Integration · 2 July 2026Mapp Biopharmaceutical's experimental MBP134 monoclonal antibody cocktail is being tested in the WHO-sponsored PARTNERS clinical trial for Bundibugyo Ebola treatment.
  • Institute of Tropical Medicine AntwerpcoreStrategic or Co-development Partner · 2 July 2026The Institute of Tropical Medicine in Belgium is a key scientific partner in the WHO-sponsored PARTNERS clinical trial for Bundibugyo Ebola treatments, collaborating with INRB and Oxford University.
  • ALIMA (The Alliance for International Medical Action)coreImplementation/ SI/ Consulting Partner · 2 July 2026ALIMA is providing clinical trial support and patient care in the Ebola response, with healthcare workers administering trials while treating patients in isolation wards.
  • UNICEF and UNFPAcoreStrategic or Co-development Partner · 26 June 2026WHO jointly implemented with UNICEF, UNFPA, and the Ishonch Fund a $43.5 million healthcare programme in Uzbekistan, modernizing 231 perinatal institutions and training over 80,000 healthcare workers.
  • Médecins Sans Frontières (MSF)coreImplementation/ SI/ Consulting Partner · 25 June 2026MSF is providing frontline medical care in the Ebola outbreak response in DRC, operating treatment centers and supporting patient care in isolation wards.
  • PAHO - Pan American Health OrganizationcoreStrategic or Co-development Partner · 25 June 2026WHO, PAHO, and the Ibero-American Road Safety Observatory held their first joint meeting in Madrid, bringing together road safety leaders from 22 Ibero-American and Caribbean countries.
  • UNICEFcoreStrategic or Co-development Partner · 24 June 2026UNICEF and Gavi have launched a global outreach programme inviting vaccine developers for the Bundibugyo Ebola strain. UNICEF procures and delivers vaccines during outbreaks.
  • UKHSA - UK Health Security AgencycoreStrategic or Co-development Partner · 12 June 2026UKHSA leads the Hantavirus Collaborative Open Research Consortium (CORC), mobilizing over 1,600 experts from 130+ countries to coordinate international research activities following the MV Hondius outbreak.
  • ANRS Emerging Infectious DiseasescoreStrategic or Co-development Partner · 12 June 2026ANRS-MIE supports coordination of the NAVIS natural history study for Andes virus across 21 countries under BE READY, an EU-funded initiative for epidemic research preparedness.
  • ISARIC - International Severe Acute Respiratory and Emerging Infection ConsortiumcoreStrategic or Co-development Partner · 12 June 2026ISARIC provides its adaptable research framework for the NAVIS study, enabling rapid, standardized data and sample collection during the Andes virus outbreak.
  • UNDPcoreStrategic or Co-development PartnerWHO collaborates with UNDP through TDR and the Global Action Plan for Healthy Lives and Well-being for All, working with 12 partner organizations to achieve health-related Sustainable Development Goals.

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

World Health Organization competitors and assessment

Company assessment

Regional players

Direct peers

  • UNICEF: Direct UN system peer sharing the same multilateral intergovernmental model with universal membership, assessed contributions, and joint country-level delivery on health-adjacent mandates (immunization, nutrition, maternal/child health).
  • UNDP (United Nations Development Programme): Closely comparable UN system sibling; jointly runs TDR with WHO and co-implements health-systems-strengthening programmes, sharing governance, funding, and country-delivery models.
  • World Bank: Co-governor of TDR and major co-financier of health systems work; comparable in scale, sovereign governance, and global development mandate, frequently partnering on pandemic preparedness and country-level health investments.
  • FAO (Food and Agriculture Organization): UN specialized agency sharing WHO's headquarters city, governance structure, and joint programmes; they jointly run Codex Alimentarius, making FAO an immediate operational peer.

Broad incumbents

  • U.S. Centers for Disease Control and Prevention (CDC): National public-health agency with overlapping technical functions (surveillance, lab capacity, outbreak response, normative guidance) and significant funding footprint; operates nationally rather than multilaterally but is a frequent operational partner.

Emerging players

  • Africa CDC: Continental public-health body increasingly coordinating African outbreak response (e.g., Bundibugyo Ebola) and seeking its own financing; partial overlap with WHO's regional delivery in Africa and a potential future alternative coordinator.
  • Gavi, the Vaccine Alliance: Public-private partnership that funds vaccine procurement and outbreak response (including committed Bundibugyo financing); partners closely with WHO but is a downstream funding mechanism rather than a normative body.
  • CEPI (Coalition for Epidemic Preparedness Innovations): Epi preparedness financing and coordination body that co-funds vaccine R&D with WHO (e.g., Bundibugyo vaccine development), partially overlapping WHO's R&D Blueprint function.

Others

  • Médecins Sans Frontières (MSF): Operational NGO partner providing frontline medical care (e.g., Bundibugyo Ebola response); adjacent enabler/implementer rather than a normative peer, but routinely collaborates with WHO on emergencies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

World Health Organization social profiles

Digital presence

World Health Organization compliance and trust

Trust signal

Compliance5 records

World Health Organization financial estimates

Financial estimate

Revenue estimate

Valuation estimate

World Health Organization leadership team

Management profile

Number of profiles

Profiles18 records

World Health Organization subsidiaries and ownership

Company hierarchy

Subsidiaries14 records

World Health Organization funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

World Health Organization M&A and investment

M&A and investment

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about World Health Organization

What does World Health Organization do?

WHO is the United Nations specialized agency for international public health, serving 194 member states through setting international health norms and standards, providing technical cooperation and capacity building to national health systems, coordinating international responses to health emergencies and disease outbreaks, and maintaining global disease surveillance and health data systems. It develops evidence-based guidelines, disseminates open-access research, runs the Emergency Use Listing procedure for diagnostics and vaccines during emergencies, and operates the WHO Academy for public health workforce learning.

Is World Health Organization a public or private company?

World Health Organization is a private company. It is classified as state government owned and is currently operating.

When was World Health Organization founded?

World Health Organization was founded in 1948. It employs 5,001 to 10,000 people.

Where is World Health Organization based?

World Health Organization is headquartered in Geneva, Switzerland, in the Europe region.

How does World Health Organization make money?

Three revenue lines are on record. Assessed Contributions from Member States are the primary driver. The others are voluntary Contributions and WHO Foundation and Partnership Funding.

Who are World Health Organization's main competitors?

European Centre for Disease Prevention and Control (ECDC) is listed as a regional player. Direct peers are UNICEF, UNDP (United Nations Development Programme), World Bank and FAO (Food and Agriculture Organization). U.S. Centers for Disease Control and Prevention (CDC) is listed as a broad incumbent. Emerging players are Africa CDC, Gavi, the Vaccine Alliance and CEPI (Coalition for Epidemic Preparedness Innovations). Médecins Sans Frontières (MSF) is listed as an others.

Does World Health Organization have an API?

No public API is recorded for World Health Organization.

What industry is World Health Organization in?

World Health Organization's product category is International Public Health. Its primary akta.pro industry code is HLAJAKAA, Multilateral Global Health Agencies (UN/IFIs), with a secondary code of BPADAAAA, United Nations System & Specialized Agencies. Its NAICS code is 92812 and its SIC code is 9721.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
ReutersWHO endorses lifestyle changes over GLP-1 drugs in child obesity fightThe World Health Organization issued global guidelines recommending diet, exercise, and counseling over weight-loss drugs for children under 10, with drugs reserved for adolescents only after failed supervised interventions. The agency cited 170 million children aged 5-19 living with obesity in 2024, and noted insufficient evidence on GLP-1 drugs.Ifeng"China plans to nominate a candidate for the position of Director-General of the World Health Organization"China plans to nominate a candidate for the World Health Organization Director-General position, aiming to reclaim the top role after many years. If Song Li succeeds, she would become the second Chinese person to hold the position, following Margaret Chan's tenure from 2007 to 2017.PBS.orgHow Russia and the world are responding to a possible case of pneumonic plague after lab worker deathThe World Health Organization said a possible pneumonic plague case in Russia poses a very low risk outside the country, following the death of a lab worker at the Irkutsk Anti-Plague Research Institute. Russian officials reported no dangerous pathogens in contacts, and WHO experts have not been deployed. The case has revived memories of the COVID-19 pandemic's origins.DevdiscourseEXCLUSIVE-China plans late entry into WHO leadership race, sources sayChina plans to nominate Song Li, a senior public health official, to lead the World Health Organization, according to four diplomats and a source. The move aims to fill the void left by the US withdrawal, which has cut funding and forced restructuring. The WHO will release nominees after regional committee meetings in early November.The Denver PostHow Russia and the world are responding to a possible case of pneumonic plague after lab worker diesThe World Health Organization said a possible pneumonic plague case in Russia poses a very low risk outside the country after a lab worker died. Russian officials reported no dangerous pathogens in contacts and placed the hospital under quarantine. WHO experts have not been deployed yet.PressdemocratHow Russia and the world are responding to a possible case of pneumonic plague after lab worker diesThe World Health Organization said a possible pneumonic plague case in Russia poses a very low risk outside the country after a lab worker died. Russian officials reported no dangerous pathogens in contacts and placed the hospital under quarantine. WHO experts have not yet been deployed to Russia.San Diego Union-TribuneHow Russia and the world are responding to a possible case of pneumonic plague after lab worker diesThe World Health Organization said a possible pneumonic plague case in Russia poses a very low risk outside the country after a lab worker died. Russian officials reported no dangerous pathogens in contacts and placed the hospital under quarantine. WHO experts have not been deployed yet.The Mercury NewsHow Russia and the world are responding to a possible case of pneumonic plague after lab worker diesThe World Health Organization said a possible pneumonic plague case in Russia poses a very low risk outside the country after a lab worker died. Russian officials reported no dangerous pathogens in contacts and placed the hospital under quarantine. WHO experts have not yet been deployed to investigate.PRESSBEEHow Russia and the World Are Responding to a Possible Case of Pneumonic Plague After Lab Worker Dies ...Middle EastThe World Health Organization said a possible pneumonic plague case in Russia presents a very low risk outside the country after a lab worker died. Russian officials reported no dangerous pathogens in contacts, and WHO experts are being mobilized. The case has revived memories of the COVID-19 pandemic.Global NewsPossible pneumonic plague case: What to know and how experts are responding - NationalThe World Health Organization said a possible pneumonic plague case in Russia presents a very low risk outside the country after a woman at a plague research institute died of pneumonia. Russian officials reported no dangerous pathogens in contacts, and WHO experts are investigating. The case has revived memories of the COVID-19 pandemic.